Valuation: Artivion, Inc.

Market Cap 1.27B 1.1B 1.03B 944M 1.78B 121B 1.81B 12.08B 4.74B 60.46B 4.77B 4.67B 201B P/E 2026 *
312x
P/E 2027 * 64.2x
Enterprise Value 1.27B 1.1B 1.03B 944M 1.78B 121B 1.81B 12.08B 4.74B 60.46B 4.77B 4.67B 201B EV / Sales 2026 *
2.61x
EV / Sales 2027 * 2.35x
Free-Float
89.39%
Yield 2026 *
-
Yield 2027 * -
1 day+2.14%
1 week-5.83%
Current month-6.61%
1 month+8.65%
3 months-26.14%
6 months-31.83%
Current year-42.13%
1 week 22.6
Extreme 22.6
24.2
1 month 20
Extreme 20
24.2
Current year 17.4
Extreme 17.4
38.9
1 year 17.4
Extreme 17.4
41.1
3 years 11.7
Extreme 11.7
41.1
5 years 10.1
Extreme 10.1
41.1
10 years 10.1
Extreme 10.1
41.1
Manager TitleAgeSince
Chief Executive Officer 59 02/09/2014
Director of Finance/CFO 53 04/12/2023
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 71 01/12/2003
Director/Board Member 66 01/12/2003
Director/Board Member 61 01/05/2012
Change 5-day change 1-year change 3-year change Capi.($)
+2.14%-5.83% - - 1.27B
+1.50%+1.43%-18.19%-1.23% 183B
+0.07%+0.06%-4.03%+1.23% 110B
-0.24%+1.30%+11.46%+69.53% 61.72B
-1.64%+7.20%+39.25%+56.58% 54.98B
+4.44%+7.32%+2.99%-35.48% 47.02B
-3.33%-10.03% - - 32.16B
+0.59%+11.05%+8.35%-31.57% 31.19B
-1.20%+2.09%+46.11%-8.45% 24.7B
-1.48%-1.71%+2.74%+0.48% 22.68B
Average +0.10%+1.40%+11.08%+6.38% 63.05B
Weighted average by Cap. +0.43%+0.19%+1.30%+8.33%

Financials

2026 *2027 *
Net sales 486M 422M 395M 361M 682M 46.32B 691M 4.62B 1.81B 23.14B 1.83B 1.79B 77.03B 540M 468M 439M 401M 757M 51.42B 767M 5.13B 2.01B 25.69B 2.03B 1.98B 85.51B
Net income 4.4M 3.82M 3.58M 3.27M 6.17M 419M 6.26M 41.83M 16.42M 209M 16.52M 16.16M 697M 22.59M 19.6M 18.35M 16.79M 31.7M 2.15B 32.11M 215M 84.27M 1.07B 84.8M 82.96M 3.58B
Net Debt - -
Logo Artivion, Inc.
Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons in treating patients with aortic diseases. The Company operates through two segments, which include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other products. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products. It is engaged in the endovascular repair of aortic arch disease and the developer of the NEXUS Aortic Arch System.
Employees
1,800
Date Price Change
06/08/26 22.60 -3.42%
05/08/26 €23.40 -1.68%
04/08/26 €23.80 0.00%
03/08/26 €23.80 -1.65%
31/07/26 €24.20 +0.83%
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
26.17USD
Average target price
42.00USD
Spread / Average Target
+60.49%

Quarterly revenue - Rate of surprise